Biodesix, Inc. (NASDAQ:BDSX) Receives $2.95 Consensus Target Price from Analysts
Shares of Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) have been given an average rating of “Buy” by the five ratings firms that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […]
Shares of Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) have been given an average rating of “Buy” by the five ratings firms that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […]
